Noile-Immune Biotech Inc.
Status: Publicly traded
Direct answer
Noile-Immune Biotech Inc. is publicly traded on JPX under the ticker 4893.T.
Established in 2015 and based in Minato, Japan, this company is dedicated to exploring and advancing CAR-T cell technology for use in cancer immunotherapy treatments.
Can you invest in Noile-Immune Biotech Inc.?
Yes. Noile-Immune Biotech Inc. trades publicly on JPX as 4893.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Noile-Immune Biotech Inc.
Detailed equity research is provided by MarketSnap.